Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05810259 · ClinicalTrials.gov registry record · NA

Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life

A NA study of Depression and Anxiety, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT05810259 is a NA study of Depression and Anxiety that is actively recruiting participants, run by Yale University. The registered enrollment target is 120 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05810259, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The study will examine the role of digital wellness modules (brief mindfulness and light to moderate physical exercise) delivered through a smartphone wellness application and their short-term effects on health behavior motivation and change, and longer-term quality of life and non-pathological affective states.

Interventions

  • DEVICE Caravan Wellness app

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-05-22
Est. Completion 2025-12
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT05810259

The ClinicalTrials.gov registry entry for NCT05810259 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Caravan Wellness app is the first listed.

NCT05810259 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05810259 about?

NCT05810259 is a clinical study titled "Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life". The study will examine the role of digital wellness modules (brief mindfulness and light to moderate physical exercise) delivered through a smartphone wellness application and their short-term effects on health behavior motivation and change, and longer-term quality of life and non-pathological affe...

What is the current status of trial NCT05810259?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-05-22. Estimated completion is 2025-12.

What conditions does trial NCT05810259 study?

This clinical trial studies the following conditions: Depression, Anxiety, Quality of Life, Wellness.

What interventions are being tested in trial NCT05810259?

The interventions under investigation include: Caravan Wellness app (DEVICE).

Who is sponsoring clinical trial NCT05810259?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05810259 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.